Home › NDC Lookup › Ingredients › Phenazopyridine Hydrochloride › 37012-0098-01
Skopko Urinary Pain Relief PHENAZOPYRIDINE HYDROCHLORIDE 95 mg Tablet, 32-count — NDC 37012-0098-01 package photo
Label image from the product's FDA listing (DailyMed) — may show a different pack size or an older label revision.

Skopko Urinary Pain Relief PHENAZOPYRIDINE HYDROCHLORIDE 95 mg Tablet, 32-count — NDC 37012-098-01 (Billing 37012-0098-01)

by Skopko · 1 CELLO PACK in 1 CARTON / 32 TABLET in 1 CELLO PACK

This is a package of 32 tablets of Skopko Urinary Pain Relief PHENAZOPYRIDINE HYDROCHLORIDE 95 mg Tablet from Skopko, marketed since Jul 2013 and currently FDA-listed. It is the main listing for this product, which comes in 2 package sizes.

NDC 37012-0098-01
🏷️ FDA NDC (as labeled) 37012-098-01 billing pads the product segment with a zero
This package
Contains32-count Pack sizes2 compare ↓
Main listing for product 37012-098 · Also comes in: 30 tablets 37012-098-30
OTC On market Non-controlled ⇄ Compare with another NDC
🗂️ FDA directory synced Oct 1, 2026 · this listing last changed Jul 24, 2026 · sources: openFDA · FDA label (DailyMed) · FDA Orange & Purple Book · First Databank · CMS NADAC, ASP, Medicare & Medicaid · RxNorm
📋 All sources & update times →

This page is curated, coded, and maintained by

Compiled from public FDA, CMS, DailyMed, NADAC, and related drug data sources. Editorial policy

Identity & classification

Regulatory identifiers FDA, NLM and CMS codes for this package

FDA NDC (as labeled) 37012-098-01
Product NDC 37012-098
11-digit billing NDC 37012009801
RxCUI 1094126
UNII 0EWG668W17
UPC 0400081004506
SPL Set ID dc614b08-461c-4e29-8e5a-eccfdd680cef
DEA schedule Non-controlled
Marketing category UNAPPROVED DRUG OTHER
Marketing status On market
FDA listing status Listed (active directory)
Marketing start 2013-07-01
Route ORAL
Dosage form TABLET
Substance PHENAZOPYRIDINE HYDROCHLORIDE

Drug-database identifiers Medi-Span GPI and First Databank GCN / HICL / AHFS classification

GPI-14 56300010100303
GPI class Urinary Pain Relief
Quick answers
  • GPI-14 (Medi-Span): 56300010100303
  • RxCUI (RxNorm): 1094126
Why two NDCs? The FDA registers this code as 37012-098-01 — a 5-3-2 layout, and that's what's printed on the package and shown on DailyMed. For insurance claims, every NDC is standardized to a uniform 11-digit 5-4-2 format by adding a zero to the product segment → 37012-0098-01. Same drug, same package — only the format differs.
Where does this data come from?
Identifiers from the FDA openFDA NDC Directory and Structured Product Labeling; RxCUI from RxNorm (NLM); GPI from Medi-Span; GCN / HIC / AHFS / legend from First Databank.

RxNorm drug class

This medicine belongs to the Other urologicals class.

Drug family (ATC) Other urologicals
Where does this data come from?
Therapeutic classes from RxNorm RxClass (U.S. National Library of Medicine) — Established Pharmacologic Class (FDA), ATC drug family (WHO) and mechanism of action, matched by this product’s RxCUI.

Clinical

📖 What it is MedlinePlus · NLM

Phenazopyridine relieves urinary tract pain, burning, irritation, and discomfort, as well as urgent and frequent urination caused by urinary tract infections, surgery, injury, or examination procedures. However, phenazopyridine is not an antibiotic; it does not cure infections.

Read the full MedlinePlus article ↗
📗 Our plain-language guide HelloPharmacist
  • It only helps with the pain — it doesn't kill the bacteria causing the infection. Think of it as taking the edge off while your antibiotic does the real work. If you have a UTI, yo...
  • Does phenazopyridine actually treat my UTI, or does it just help with the pain?
  • That's completely expected with phenazopyridine — it's one of the most common things people notice. The drug itself has an orange-red dye, and it passes into your urine, which is w...
  • Why is my urine turning orange or red? Should I be worried?
📖 Read our full Phenazopyridine guide →

Supplement & herbal interactions

🌿 Drug–supplement interaction checker →
Where does this data come from?
Plain-language summary from MedlinePlus (U.S. National Library of Medicine); supplement & herbal interactions and nutrient depletion data from the Natural Medicines database; our full guide is HelloPharmacist editorial content.

Pricing

A drug doesn't have one price. Each row is a different public payment system, and none is what you'd pay at the counter — that depends on your insurance. The ⓘ on each row explains what it measures.

Price systemPer eachPer package
Retail pharmacies payNADAC · weekly Not in the retail survey — common for institutional, discontinued, or low-volume packs.
Medicaid paysCMS SDUD · 12 mo No recent Medicaid claims on file for this NDC — rare and low-volume NDCs are suppressed in the public data.
Medicare drug plans payPart D · quarterly No Part D plan price is available for this NDC in our data.
ℹ️
No price is published for this exact package yet. CMS surveys NADAC per package size, so a different pack of the same drug often has one.
Try another pack size: 30 tablets
Where does this data come from?
NADAC (National Average Drug Acquisition Cost) is the CMS weekly pharmacy-acquisition-cost survey — what pharmacies pay. ASP (Average Sales Price) is the CMS Medicare Part B drug-payment file, published quarterly. Medicaid pays is computed by us from CMS State Drug Utilization Data (total reimbursed ÷ units, trailing 12 months) — gross of rebates and inclusive of dispensing fees, so it reflects what Medicaid paid, not an acquisition cost. Medicare drug plans pay is the median negotiated point-of-sale unit cost across plans listing this NDC in the CMS quarterly Prescription Drug Plan pricing files, before rebates. The VA pays is the federal contract price (FSS, and the statutory Big 4 ceiling where listed) from the VA National Acquisition Center pharmaceutical price file. All are free public government data; each measures a different payer, so the figures are not directly comparable.

Packaging — all sizes for this product

Package NDCDescription Marketing startMarketing endStatus
37012-0098-01 You're viewing this Main listing 1 CELLO PACK in 1 CARTON / 32 TABLET in 1 CELLO PACK 2013-07-01 — Active
37012-0098-30 37012-098-30 30 TABLET in 1 CELLO PACK 2013-07-01 — Active

Pack size FAQ

What quantity is in this package?
This is a 32-count package — 1 cello pack in 1 carton / 32 tablet in 1 cello pack.
How does this package differ from NDC 37012-0098-30?
Both are Skopko Urinary Pain Relief PHENAZOPYRIDINE HYDROCHLORIDE 95 mg Tablet — the drug itself is identical. This page's package is the 32-count one, while NDC 37012-0098-30 is the 30 tablets package.
What NDC number is used to bill for this package of Skopko Urinary Pain Relief PHENAZOPYRIDINE HYDROCHLORIDE 95 mg Tablet?
Use the 11-digit billing form listed in the identifiers section of this page. Pharmacy and medical claims use the 11-digit form; the FDA label may print a shorter form of the same code.

Therapeutic equivalents

ProductLabelerPackNADAC/unitTEStatusPrice vs. this
Quality Choice Urinary Pain Relief 95 mg 63868-0117-30 Chain 30 tablets $0.118 — FDA listed —
HealthMart Urinary Pain Relief 95 mg 62011-0325-01 Strategic 30 tablets $0.120 — FDA listed —
Rugby Phenazopyridine HCl Urinary Tract Analgesic 95 mg 00536-1411-07 Rugby 30 tablets $0.132 — Availability likely —
Good Neighbor Pharmacy Urinary Pain Relief 95 mg 46122-0337-65 AmerisourceBergen 30 tablets $0.132 — Availability likely —
Uro-Pain 95 mg 57237-0331-03 Rising 30 tablets $0.132 — Availability likely —
Leader Urinary Pain Relief 95 mg 70000-0243-01 Cardinal 30 tablets $0.132 — Availability likely —
Foster and Thrive Neighbor Pharmacy Urinary Pain Relief 95 mg 70677-1229-01 Strategic 30 tablets $0.132 — Availability likely —
Sunmark Urinary Pain Relief 95 mg 49348-0076-44 Strategic 30 tablets $0.132 — Availability likely —
Walgreens Urinary Pain Relief 95 mg 00363-7775-30 Walgreens 30 tablets — — FDA listed —
CVS Health Urinary Pain Relief 95 mg 10956-0001-30 Reese 30 tablets — — FDA listed —
Preferred Urinary Pain Relief 95 mg 10956-0551-30 Reese 30 tablets — — FDA listed —
Rite Aid Urinary Pain Relief 95 mg 11822-8855-06 Rite 30 tablets — — FDA listed —
Kroger Urinary Pain Relief 95 mg 30142-0564-30 THE 30 tablets — — FDA listed —
TopCare Urinary Pain Relief 95 mg 36800-0040-30 TOPCO 30 tablets — — FDA listed —
Skopko Urinary Pain Relief 95 mgthis 37012-0098-01 Skopko 32 tablets — — FDA listed —
Azo 95 mg 49973-0301-31 i-Health, 30 tablets — — FDA listed —
Phenazopyridine Hydrochloride 95 mg 68071-2273-03 NuCare 30 tablets — — FDA listed —
Good Neighbor Pharmacy Urinary Pain Relief 95 mg 71205-0584-30 Proficient 30 tablets — — FDA listed —
Quality Choice Urinary Pain Relief 95 mg 83324-0201-30 Chain 30 tablets — — FDA listed —
About this product: other versions of the same ingredient, strength and form are listed above, least expensive first, with FDA equivalence ratings where available.
Where does this data come from?
Equivalents are other NDCs of the same ingredient, form and route from the openFDA NDC Directory, ranked least-expensive-first by NADAC. Therapeutic-equivalence (AB) ratings come from the FDA Orange Book; biologics use the FDA Purple Book for biosimilar & interchangeable status.

Availability & generic status

🏛️
2013
On the market since
Jul 2013
📍
2026
Currently FDA-listed
13 years listed
🔒
·
No generic listed yet
brand only
ℹ️No FDA-approved generic found

We did not find an FDA-approved generic match for this exact strength, form and route.

Where does this data come from?
Patents and exclusivity from the FDA Orange Book (small-molecule drugs), refreshed from public FDA data. Generic launch timing is an estimate, not a guarantee.

Inactive Ingredients / Excipients

Inactive ingredients, also called excipients, are components of the drug product other than the active ingredient. They may include fillers, dyes, coatings, preservatives, flavors, or other formulation ingredients.

Loading inactive ingredients from the official FDA label in the background. No external source is being called by this page request.
Where does this data come from?
Source: official FDA Structured Product Labeling (SPL) via DailyMed and the openFDA label index. Structured IACT rows and label-wide narrative are kept separate; availability and product-level specificity depend on the submitted label.

Inactive ingredient FAQ

Are inactive ingredients the same for every manufacturer?
No. Inactive ingredients can differ by manufacturer, dosage form, strength, and package / product version.
Why might an inactive ingredient be missing?
Some SPLs do not provide a complete structured inactive-ingredient list, and older or unusual labels may only include the information in narrative text.
Can inactive ingredients matter?
Yes. They can matter for allergies, intolerances, dyes, gluten / lactose concerns, preservatives, and formulation differences — but confirm with a pharmacist or the manufacturer when it’s clinically important.

Manufacturer & labeler

LabelerSkopko
Labeler code37012
First marketedJul 2013
Product typeHuman Otc Drug
The labeler markets the product; the application holder owns the FDA approval. They’re often the same company but can differ (e.g. a repackager or an authorized generic). A mailing address / phone appears here when the manufacturer includes it in the product’s FDA label (not all do).
Where does this data come from?
Labeler, application holder and registered establishment from the FDA openFDA NDC Directory and Drugs@FDA; address/contact from the product’s FDA label.

FDA label — Drug Facts FDA SPL

The complete FDA label for this product — the official Drug Facts labeling, verbatim, section by section. Jump with a chip, search within the label, or expand everything.
🎯 Indications and Usage ⏱️ Dosage and Administration ⚠️ Warnings 🧪 Active Ingredient 🧪 Inactive Ingredients 🎯 Purpose 📄 Ask a Doctor Before Use If 📄 When Using This Product 📄 Stop Use and Ask a Doctor If 🤰 If Pregnant or Breast-Feeding 📄 Keep Out of Reach of Children
🎯 Indications and Usage 13 words ▾

Uses fast relief from urinary pain,burning,urgency and frequency associated with urinary tract infections.

⏱️ Dosage and Administration 48 words ▾

Directions ■ Adults and children 12 and over: take 2 tablets 3 times daily with a full glass of water, with or after meals as needed ■ Children under 12: consult a doctor ■ Do not use for more than 2 days (12 tablets) without consulting a doctor

⚠️ Warnings 6 words ▾

Warning Do not exceed recommended dosage

🧪 Active Ingredient 6 words ▾

Active Ingredient Phenazopyridine Hydrochloride 95 mg

🧪 Inactive Ingredients 21 words ▾

Inactive Ingredients magnesium stearate,microcrystalline cellulose.May also contain carnauba wax, croscarmellose sodium,hypromellose,lactose,magnesium silicate,maize starch,pharmaceutical glaze,polyethylene glycol,povidone,pregelatinized starch,sodium starch glycolate. image of carton

🎯 Purpose 3 words ▾

Purpose Urinary Analgesic

📄 Ask a Doctor Before Use If 24 words ▾

Ask Doctor before use if you have ■ kidney disease ■ allergies to foods, preservatives or dyes ■ had a hypersensitive reaction to Phenazopyridine

📄 When Using This Product 48 words ▾

When using this product ■ When using this product stomach upset may occur, taking this product with or after meals may reduce stomach upset ■ your urine will become reddish-orange in color. This is not harmful, but care should be taken to avoid staining clothing or other items.

📄 Stop Use and Ask a Doctor If 28 words ▾

Stop use and ask a doctor if ■ your symptoms last for more than 2 days ■ you suspect you are having an adverse reaction to the medication

🤰 If Pregnant or Breast-Feeding 11 words ▾

If pregnant or breast feeding ask a health professional before use.

📄 Keep Out of Reach of Children 22 words ▾

Keep out of the reach of children in case of an overdose,get medical help or contact a Poison Control Center right away.

Source: FDA Structured Product Labeling, mirrored from DailyMed / openFDA. Prefer the government’s original formatting? View this label on DailyMed ↗

About this NDC listing & data coverage

Over-the-counter (OTC) product Marketed without an FDA application

Listed without an FDA application

This product's marketing category indicates it is marketed without an approved FDA application (no NDA, ANDA, or BLA on file). Having an NDC does not by itself establish FDA approval — the NDC Directory is a listing system, not an approval decision. Approval-linked data such as Orange Book therapeutic-equivalence ratings therefore does not apply.

What data is (and isn’t) available for this NDC — tap to expand
NDC identity (package / product / labeler codes) ✓ Available
Labeler ✓ Available
Product & package description ✓ Available
Marketing category & status ✓ Available
Active ingredient / dosage form / route ✓ Available
FDA label (SPL via DailyMed) ✓ Available
Package photos ✓ Available
Inactive ingredients (structured) — Not published for this NDC The labeler did not submit a structured excipient list, or no SPL is available.
NADAC pharmacy acquisition price (CMS) — Not published for this NDC CMS publishes NADAC only for NDCs reported in its retail-pharmacy survey.
Orange Book / therapeutic-equivalence data — Not published for this NDC Applies only to products approved under an NDA/ANDA; many listings are out of scope.
HCPCS J-code billing crosswalk — Not published for this NDC Most self-administered / retail products have no J-code — that is normal.
Medicaid utilization (CMS SDUD) — Not published for this NDC CMS reports utilization only for NDCs with Medicaid claims above its privacy threshold.
“Not published” reflects what the public FDA / CMS / NLM sources provide for this exact package code — it is a property of the data feeds, not a judgment about the product.

Questions about this listing

Is this NDC FDA-approved?
An NDC listing does not by itself establish FDA approval — the NDC Directory records that a product is listed with FDA, not that it was reviewed and approved. This listing's marketing category is "Unapproved Drug Other". Products approved under an application carry an NDA, ANDA, or BLA number.
Why is there no price listed?
The pricing shown on our NDC pages comes from CMS NADAC, a voluntary survey of retail community pharmacy invoices. CMS does not publish a NADAC for every NDC — packages outside the retail survey (institutional and hospital products, bulk packages, discontinued items, and many OTC items) may never receive one. A missing price reflects the survey's scope, not this product's actual cost, and does not mean the product is free or unavailable.
Is the NDC printed on the package the same as the 11-digit billing NDC?
Yes, they identify this exact package in different formats. The form printed on the packaging and shown on DailyMed is the one the FDA registered. Insurance claims use a fixed 11-digit 5-4-2 format, so the short segment is padded with a leading zero and the dashes are dropped. The Identity section at the top of this page lists each form of this code.
Is this package still being marketed?
Yes, per the latest FDA NDC Directory data on this page: this package is listed as actively marketed, with no marketing end date reported by Skopko. Listing status can change — the directory data on this page refreshes weekly.
Does this product come in other package sizes?
Yes — the FDA directory lists 1 other package presentation of this same product, including 30 tablets (37012-0098-30). Each has its own NDC and its own page — see the package list near the top of this page.
Who lists this product with the FDA?
Skopko is the labeler of record for this NDC — the company under whose FDA-assigned code the package is listed. The labeler may be the manufacturer itself or a distributor marketing the product under its own code.
Do I need a prescription for this product?
This NDC is listed with FDA as an over-the-counter product, so it does not require a prescription. Follow the package directions, and ask your pharmacist if you are unsure whether it is right for you.
This page identifies an FDA-listed package (the NDC) and reports public regulatory and pricing data about the listing. It is reference information, not a medical recommendation — talk to your pharmacist or prescriber about your own medication.
Where does this data come from?
Listing facts (marketing category, packager status, marketing dates) from the FDA openFDA NDC Directory; label availability from DailyMed; pricing coverage from CMS NADAC; equivalence scope from the FDA Orange Book.
← 37012-0089-02 · Shopko 37662-0001-01 · Hahnemann →
For educational and professional reference only — not medical advice. Pricing reflects published NADAC and CMS ASP (free public data) and may differ from your acquisition cost; always verify before billing or dispensing.